Epidemiology
Rare localizations
bladder
uterine cervix (#14599884#)
prostate
spermatic cord
biliary tract, ampulla of Vater (#2286899#)
orbite
long bones (#8554114#), mandible (#12598923#)
Predisposition
Li-Fraumeni syndrome (TP53 germline mutations) (#16206219#)
variegated mosaic aneuploidy syndrome (#14608201#)
CGH (#11807989#)
| gains | 2q | Chr.3 | 7q | 8p | 11q | 12q13-15 | 13q14 | 20p | |
| % | 40% | - | 31% | 53% | 31% | 49% | 22% | 31% | |
| losses | 1p36 | 3p14-21 | 9q21-22 | 10q22-qter | Chr.14 | 16q | 17p | Chr.22 | Chr.X |
| % | 27% | 22% | 33% | 18% | - | 27% | 22% | 22% | - |
Allelotype (#9315099#)
11q LOH
11p15.5 LOH
Molecular biology
disruption of imprinted genes at chromosome region 11p15.5 (#10935489#)
mutations in PTCH1 gene coding for Patched-1 at 9q22.3
Genomic amplification
IGF1R (insulin-like growth factor type I receptor) at 15q25-26 (15q25-26 amplicon)
Cytogenetics
trisomy 2, trisomy 8, trisomy 13
Chr.1 rearrangements
der(2)t(2;7)(q36-q37;q3?) (#12550761#)
del(14)(q24) (#12550761#)
der(16)t(1;16)(q21;q13) (#12550761#)
Expression profiling (#12845631#)
Differential diagnosis
See also
References
Anderson J, Gordon A, Pritchard-Jones K, Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer. 1999 Dec;26(4):275-85. Review. PMID: #10534762#







